Past Forums
14th Paediatric Strategy Forum
ON Novel ways to target and enhance efficiency of anti-GD2 therapies
24 - 25 October 2024, Amsterdam
13th Paediatric Strategy Forum
for diffuse midline gliomas
8 - 9 May 2024, Toronto
Scientific manuscript: HERE
12TH Paediatric Strategy Forum
for CDK4/6, CDK 7 and CDK 9 Inhibitors
26-27 October 2023, Amsterdam
Scientific manuscript: HERE
11TH Paediatric Strategy Forum
for PI3K, mTOR and AKT inhibitors
3-4 April 2023, Boston
Scientific manuscript: HERE
10TH Paediatric Strategy Forum
for DNA Damage Pathway Inhibitors
27-28 October 2022, Amsterdam
Scientific manuscript: HERE
9TH PAEDIATRIC STRATEGY FORUM
FOR MEDICINAL PRODUCT DEVELOPMENT IN MAPK PATHWAY INHIBITORS
28 March & 29 March 2022, Virtual
Scientific manuscript: HERE
8TH PAEDIATRIC STRATEGY FORUM
FOR MEDICINAL PRODUCT DEVELOPMENT OF MULTI-TARGETED KINASE INHIBITORS IN BONE SARCOMA
30 November & 1 December 2021, Virtual
Scientific manuscript: HERE
7TH PAEDIATRIC STRATEGY FORUM FOR MEDICINAL PRODUCT DEVELOPMENT OF CAR T-CELLS IN CHILDREN AND ADOLESCENTS
25-27 May 2021, Virtual
Scientific manuscript: HERE
6th Paediatric Strategy Forum
for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies
13-14 January 2021, Virtual
Scientific manuscript: HERE
5th Paediatric Strategy Forum for Medicinal Product Development of Epigenetic Modifiers in Children and Adolescents
11-12 April 2019, Rotterdam
3rd Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients
5-6 September 2018, EMA, London
2nd Paediatric Strategy Forum for Medicinal product development for mature B-cell malignancies in children
13-14 November 2017, EMA, London
1st Paediatric Strategy Forum
for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies
30-31 January 2017, EMA, London
Public summary: HERE
